Breaks Categories: News

FridayDec 06, 2024 9:58 am

NetworkNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Launches $50 Million At-the-Market Equity Program

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) as entered into an equity distribution agreement with BMO Nesbitt Burns Inc., Beacon Securities Limited, and BMO Capital Markets Corp. to establish a new at-the-market equity program ("2024 ATM Program"). The program allows the company to sell up to $50 million in common shares through market-based transactions at prevailing prices, with proceeds designated for pre-construction site work and phase one development at the Waterberg Project, a Saudi Arabia smelter feasibility study, and general corporate purposes. The agreement is valid until December 2026 or until the $50 million cap is reached, with sales…

Continue Reading

ThursdayDec 05, 2024 3:21 pm

NetworkNewsBreaks – Synergy CHC Corp. (NASDAQ: SNYR) Completes $10M IPO

Synergy (NASDAQ: SNYR), a provider of consumer health care, beauty and lifestyle products, announced the completion of its initial public offering of 1,150,000 shares of its common stock at $9.00 per share. The shares began trading on the Nasdaq Global Market under the ticker symbol SNYR on Oct. 23, 2024. In addition, Synergy granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock at the public offering price less underwriting discounts and commissions. Synergy received approximately $8.4 million in net proceeds from the offering of which it intends to use to repay a…

Continue Reading

ThursdayDec 05, 2024 2:55 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Strategic Board Appointment

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in the development of inflammation and immunology (“I&I”) biological products and offering CDMO services through its Scinai Bioservices unit, today announced the appointment of Prof. Michael Schön to its Scientific Advisory Board (“SAB”). Recognized with numerous awards for his groundbreaking research on immune reactions in inflammation, Prof. Michael Schön is a distinguished professor and director of the Department of Dermatology, Venereology and Allergology at the University Medical Center Göttingen. He also serves as vice dean and deputy director for research and teaching and is the former director of the Lower Saxony Institute…

Continue Reading

ThursdayDec 05, 2024 2:46 pm

NetworkNewsBreaks – Branded Legacy Inc. (BLEG) Reaffirms Commitment to Growth and Innovation in Biotech, Wellness Sectors

Branded Legacy (OTC: BLEG) today announced updates as it confronts recent challenges and charts a focused path forward. In the announcement, the company reaffirmed its commitment to the biotech and wellness sectors, with its primary focus on expanding its wholly owned subsidiary, Sycamore BioPharma. “These challenges have only strengthened our resolve,” stated Branded Legacy CEO Dave Oswald. “While the actions of former employees have created significant hurdles, our commitment to growth and innovation remains unwavering. By focusing on our more successful subsidiaries and securing the necessary funding to expand, we are poised to recover and achieve even greater success in…

Continue Reading

ThursdayDec 05, 2024 1:15 pm

NetworkNewsBreaks – AROYA Showcasing Future of Cultivation at MJBizCon 2024

AROYA by Addium, a leader in data-driven cultivation solutions, is unveiling groundbreaking innovations at the Marijuana Business Conference (“MJBizCon”), taking place in the Las Vegas Convention Center from Dec. 4–6, 2024. As a leading innovator in cannabis cultivation, AROYA is reimagining precision substrate irrigation and positioning a bold new brand tailored to the future. “AROYA continues to push boundaries with pioneering technology that empowers growers to maximize their yield and operate more efficiently,” said AROYA VP of Marketing, Christian Hertel. “We are excited to showcase our new irrigation solutions to MJBizCon 2024 attendees and demonstrating a simpler, smarter way to…

Continue Reading

ThursdayDec 05, 2024 12:32 pm

NetworkNewsBreaks – PayPal Holdings Inc. (NASDAQ: PYPL) Makes Headlines with Recent Innovation Announcement

PayPal (NASDAQ: PYPL), a global leader in digital payments, recently unveiled its newest offering, PayPal Pay Later API, designed to enhance the flexibility and convenience of online purchases for consumers. Announced in its most recent press release, the API allows merchants to seamlessly integrate “buy now, pay later” functionality into their platforms, expanding PayPal’s suite of financing solutions. The move underscores the company’s commitment to empowering merchants and consumers alike, particularly as competition in the fintech space intensifies. With the holiday shopping season in full swing, PayPal anticipates a surge in adoption, positioning the company for strong performance in the…

Continue Reading

ThursdayDec 05, 2024 11:00 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Host Virtual Analyst & Investor Day on December 11

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for brain and central nervous system cancers, will host a Virtual Analyst & Investor Day on December 11 from 11:30 a.m. to 1 p.m. ET. The event will feature presentations by the company’s leadership team, including CEO John Climaco, Chief Medical Officer Dr. Sandra Silberman, and VP of Clinical Operations Zena Muzyczenko, alongside key opinion leaders Dr. Michael Weller, Dr. Samuel Goldlust, and Dr. Erin Dunbar. Discussions will focus on glioblastoma multiforme (“GBM”), updates on the clinical development of Berubicin, and regulatory strategies for the company’s second asset, TPI 287. A…

Continue Reading

ThursdayDec 05, 2024 10:52 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Secures Order for Class 3 EV Trucks from Bay Area Distributor

Mullen Automotive (NASDAQ: MULN) has received an order from Associated Coffee, a San Francisco Bay Area distributor, for 10 Class 3 EV cab chassis trucks. Fulfilled by authorized dealer Papé Group, the order supports Associated Coffee’s sustainability-focused operations, which prioritize reduced carbon footprint and efficiency. Mullen’s commercial EVs, including the Class 3 Mullen THREE, are designed for urban last-mile delivery and meet stringent emissions standards. The Mullen THREE also offers significant financial incentives, with up to $52,500 in rebates and tax credits, aligning with Associated’s commitment to environmentally conscious practices. To view the full press release, visit https://nnw.fm/xLSjU About Mullen Automotive…

Continue Reading

ThursdayDec 05, 2024 9:30 am

NetworkNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Collaborates to Integrate Advanced AI Capabilities into Flagship Platform

Thumzup (NASDAQ: TZUP), an emerging leader in social media branding and marketing solutions, has announced a strategic partnership with Tedras Global Solutions, LLC and its principal, Courtney Doutherd, a globally recognized software engineer and artificial intelligence (“AI”) expert. According to the announcement, the collaboration aims to integrate state-of-the-art AI into Thumzup’s flagship ad-tech platform, marking a bold step toward redefining social media advertising. “We are excited to welcome Courtney to the team,” said Robert Steele, CEO of Thumzup. “His vast expertise in AI and programmatic systems should accelerate the execution of our vision to deliver next-generation technology to consumers and…

Continue Reading

ThursdayDec 05, 2024 9:10 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Highlights Innovations in Neurodegenerative Drug Development on Today’s Marketplace

Annovis Bio (NYSE: ANVS), a leader in developing treatments for neurodegenerative diseases, was recently featured on Today’s Marketplace in an exclusive interview with Dr. Maria Maccecchini, Founder, President, and CEO. Dr. Maccecchini detailed Annovis Bio’s groundbreaking drug development targeting toxic proteins responsible for nerve cell damage in Alzheimer’s and Parkinson’s, as well as the company’s next-phase clinical trials. Emphasizing the broader impact of these diseases on caregivers as well as patients, Dr. Maccecchini shared insights into the meaningful progress Annovis Bio is making. The Today’s Marketplace feature continues to spotlight Annovis Bio’s leadership in addressing critical healthcare challenges, reinforcing its…

Continue Reading